One trial first evaluated in humans an antigen designed with computational tools; although the vaccine proved to be safe, it will still have to prove that it offers effective protection
One trial first evaluated in humans an antigen designed with computational tools; although the vaccine proved to be safe, it will still have to prove that it offers effective protection
One of the characteristics of viruses such as SARS-CoV-2, responsible for the Covid-19 pandemic, is its ability to undergo mutations and generate new variants, which requires constant updating of existing vaccines so that they continue to be effective against new strains. This makes us, in a way, always a step back.